Biogen reported $100K in Ordinary Share Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Abbvie ABBV:US $ 18M 0M
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Acorda Therapeutics ACOR:US $ 0.01M 0M
ALKERMES ALKS:US $ 1.68M 0.02M
Amgen AMGN:US $ 31247M 849M
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.71M 0M
Bristol Myers Squibb BMY:US $ 292M 0M
Eli Lilly And LLY:US $ 594.1M 2.2M
Esperion Therapeutics ESPR:US $ 61K 0
Gilead Sciences GILD:US $ 1M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
Intra Cellular Therapies ITCI:US $ 0.01M 0M
Marinus Pharmaceuticals MRNS:US $ 0.04M 0M
Merk MRK:US $ 1788M 0M
Moderna Inc MRNA:US 40K 40K
Novartis NOVN:VX SF 901M 0M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sangamo Biosciences SGMO:US $ 1.47M 0.01M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Seattle Genetics SGEN:US $ 0.18M 0M
Teva Pharmaceutical TEVA:IT 57M 0
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
United Therapeutics UTHR:US $ 0.7M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0.1M
YTE INCY:US $ 0.22M 0M